Literature DB >> 8632767

Reserpine inhibits amphetamine action in ventral midbrain culture.

D Sulzer1, C St Remy, S Rayport.   

Abstract

Although amphetamine releases catecholamines from isolated secretory vesicles, a number of in vivo experiments have indicated that the vesicular amine transport blocker reserpine does not block amphetamine-induced release. To address this paradox, we examined the effect of reserpine on amphetamine-induced dopamine release from postnatal ventral midbrain neurons in culture. These cultures provide a preparation in which intracellular, extracellular, and releasable dopamine pools can be measured simultaneously. We found that 1 microM reserpine for 90 min reduced stimulation-dependent dopamine release by > 95%. In parallel, reserpine reduced amphetamine-induced dopamine release by > 95% compared with cells not exposed to reserpine or by 75% compared with reserpine-treated cultures. This shows that amphetamine acts principally by redistributing dopamine from synaptic vesicles to the cytosol.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632767

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in Parkinsonian rats.

Authors:  W Y Lee; J W Chang; N L Nemeth; U J Kang
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

2.  Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size.

Authors:  E N Pothos; V Davila; D Sulzer
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

3.  Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway.

Authors:  Julie Lotharius; Jeppe Falsig; Johan van Beek; Sarah Payne; Ralf Dringen; Patrik Brundin; Marcel Leist
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

4.  Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis.

Authors:  Kristin E Larsen; Edward A Fon; Teresa G Hastings; Robert H Edwards; David Sulzer
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

5.  Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.

Authors:  Martine C J van der Elst; Yvette S Wunderink; Bart A Ellenbroek; Alexander R Cools
Journal:  Psychopharmacology (Berl)       Date:  2006-10-10       Impact factor: 4.530

6.  A fluorescent nanosensor paint detects dopamine release at axonal varicosities with high spatiotemporal resolution.

Authors:  Sofia Elizarova; Abed Alrahman Chouaib; Ali Shaib; Björn Hill; Florian Mann; Nils Brose; Sebastian Kruss; James A Daniel
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-25       Impact factor: 12.779

7.  N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux.

Authors:  B Torres; A E Ruoho
Journal:  Neuroscience       Date:  2013-12-07       Impact factor: 3.590

8.  Dopamine neurons make glutamatergic synapses in vitro.

Authors:  D Sulzer; M P Joyce; L Lin; D Geldwert; S N Haber; T Hattori; S Rayport
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

9.  Action potentials and amphetamine release antipsychotic drug from dopamine neuron synaptic VMAT vesicles.

Authors:  Kristal R Tucker; Ethan R Block; Edwin S Levitan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.